Operating Income Summary of PetMed Express, Inc.

PetMed Express, Inc.'s latest annual operating income in 2024 was -8.16 Million USD , down -470.77% from previous year.
PetMed Express, Inc.'s latest quarterly operating income in 2024 FY was -6.96 Million USD , down -386.85% from previous quarter.
PetMed Express, Inc. reported an annual operating income of -1.43 Million USD in 2023, down -105.56% from previous year.
PetMed Express, Inc. reported an annual operating income of 25.71 Million USD in 2022, down -31.6% from previous year.
PetMed Express, Inc. reported a quarterly operating income of -2.27 Million USD for 2024 Q3, down -415.65% from previous quarter.
PetMed Express, Inc. reported a quarterly operating income of -2.12 Million USD for 2024 Q1, up 70.08% from previous quarter.

Annual Operating Income Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Operating Income of PetMed Express, Inc. (2024 - 2000)

Year	Operating Income	Operating Income Growth
2024	-8.16 Million USD	-470.77%
2023	-1.43 Million USD	-105.56%
2022	25.71 Million USD	-31.6%
2021	37.58 Million USD	21.34%
2020	30.97 Million USD	-32.91%
2019	46.17 Million USD	-11.44%
2018	52.13 Million USD	39.09%
2017	37.48 Million USD	15.73%
2016	32.38 Million USD	17.29%
2015	27.61 Million USD	-2.14%
2014	28.21 Million USD	4.49%
2013	27 Million USD	3.78%
2012	26.02 Million USD	-21.2%
2011	33.02 Million USD	-18.54%
2010	40.54 Million USD	18.54%
2009	34.2 Million USD	22.17%
2008	27.99 Million USD	30.21%
2007	21.5 Million USD	18.49%
2006	18.14 Million USD	45.14%
2005	12.5 Million USD	35.72%
2004	9.21 Million USD	164.47%
2003	3.48 Million USD	365.68%
2002	747.94 Thousand USD	128.34%
2001	-2.63 Million USD	-66.45%
2000	-1.58 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q4	-3.93 Million USD	-73.04%
2024 Q3	-2.27 Million USD	-415.65%
2024 Q1	-2.12 Million USD	70.08%
2024 Q2	-441 Thousand USD	79.28%
2024 FY	-6.96 Million USD	-386.85%
2023 Q1	3.49 Million USD	-50.55%
2023 FY	-1.43 Million USD	-105.56%
2023 Q2	2.96 Million USD	-15.16%
2023 Q3	-769 Thousand USD	-125.97%
2023 Q4	-7.11 Million USD	-824.84%
2022 Q1	5.41 Million USD	-35.39%
2022 FY	25.71 Million USD	-31.6%
2022 Q2	8.08 Million USD	49.23%
2022 Q4	7.05 Million USD	37.11%
2022 Q3	5.14 Million USD	-36.35%
2021 Q2	10.47 Million USD	10.97%
2021 FY	37.58 Million USD	21.34%
2021 Q3	9.29 Million USD	-11.25%
2021 Q4	8.38 Million USD	-9.75%
2021 Q1	9.43 Million USD	10.84%
2020 Q4	8.51 Million USD	7.32%
2020 Q3	7.93 Million USD	-5.24%
2020 Q1	6.16 Million USD	-21.03%
2020 Q2	8.37 Million USD	35.87%
2020 FY	30.97 Million USD	-32.91%
2019 Q2	13.2 Million USD	-16.21%
2019 Q1	15.75 Million USD	12.52%
2019 FY	46.17 Million USD	-11.44%
2019 Q4	7.8 Million USD	-17.11%
2019 Q3	9.41 Million USD	-28.71%
2018 Q2	12.24 Million USD	-15.04%
2018 Q1	14.41 Million USD	23.25%
2018 Q4	14 Million USD	22.11%
2018 FY	52.13 Million USD	39.09%
2018 Q3	11.46 Million USD	-6.37%
2017 Q4	11.69 Million USD	52.8%
2017 Q2	7.73 Million USD	-25.66%
2017 Q1	10.4 Million USD	21.14%
2017 FY	37.48 Million USD	15.73%
2017 Q3	7.65 Million USD	-0.98%
2016 Q4	8.58 Million USD	12.63%
2016 FY	32.38 Million USD	17.29%
2016 Q3	7.62 Million USD	7.5%
2016 Q2	7.09 Million USD	-22.01%
2016 Q1	9.09 Million USD	16.27%
2015 Q1	7.83 Million USD	9.75%
2015 Q2	4.29 Million USD	-45.27%
2015 Q3	7.66 Million USD	78.69%
2015 Q4	7.81 Million USD	2.0%
2015 FY	27.61 Million USD	-2.14%
2014 FY	28.21 Million USD	4.49%
2014 Q2	6.53 Million USD	-12.87%
2014 Q3	7.04 Million USD	7.88%
2014 Q4	7.14 Million USD	1.35%
2014 Q1	7.49 Million USD	3.18%
2013 FY	27 Million USD	3.78%
2013 Q4	7.26 Million USD	0.79%
2013 Q3	7.2 Million USD	13.96%
2013 Q2	6.32 Million USD	1.97%
2013 Q1	6.2 Million USD	-1.13%
2012 Q4	6.27 Million USD	2.84%
2012 Q2	6.08 Million USD	-19.63%
2012 FY	26.02 Million USD	-21.2%
2012 Q3	6.1 Million USD	0.36%
2012 Q1	7.56 Million USD	17.43%
2011 Q4	6.44 Million USD	-8.33%
2011 FY	33.02 Million USD	-18.54%
2011 Q3	7.02 Million USD	-9.06%
2011 Q1	11.82 Million USD	21.58%
2011 Q2	7.72 Million USD	-34.67%
2010 Q1	12.59 Million USD	43.06%
2010 Q2	9.83 Million USD	-21.97%
2010 FY	40.54 Million USD	18.54%
2010 Q3	8.38 Million USD	-14.71%
2010 Q4	9.72 Million USD	16.02%
2009 Q1	9.76 Million USD	36.82%
2009 Q2	8.41 Million USD	-13.75%
2009 Q4	8.8 Million USD	22.1%
2009 FY	34.2 Million USD	22.17%
2009 Q3	7.21 Million USD	-14.34%
2008 Q4	7.13 Million USD	13.17%
2008 FY	27.99 Million USD	30.21%
2008 Q3	6.3 Million USD	3.6%
2008 Q2	6.08 Million USD	-28.14%
2008 Q1	8.46 Million USD	50.63%
2007 FY	21.5 Million USD	18.49%
2007 Q4	5.62 Million USD	45.46%
2007 Q3	3.86 Million USD	-19.48%
2007 Q2	4.8 Million USD	-33.44%
2007 Q1	7.21 Million USD	44.44%
2006 Q4	4.99 Million USD	28.31%
2006 Q3	3.89 Million USD	-2.42%
2006 Q2	3.98 Million USD	-24.39%
2006 Q1	5.27 Million USD	39.17%
2006 FY	18.14 Million USD	45.14%
2005 Q2	2.85 Million USD	4.79%
2005 Q1	2.72 Million USD	26.26%
2005 Q3	3.12 Million USD	9.56%
2005 Q4	3.78 Million USD	21.08%
2005 FY	12.5 Million USD	35.72%
2004 Q2	2.92 Million USD	36.4%
2004 FY	9.21 Million USD	164.47%
2004 Q3	1.97 Million USD	-32.53%
2004 Q1	2.14 Million USD	80.33%
2004 Q4	2.15 Million USD	9.25%
2003 FY	3.48 Million USD	365.68%
2003 Q1	1.29 Million USD	7.24%
2003 Q4	1.19 Million USD	71.76%
2003 Q2	307.75 Thousand USD	-76.17%
2003 Q3	693.26 Thousand USD	125.27%
2002 Q1	-880.76 Thousand USD	20.18%
2002 Q4	1.2 Million USD	226.8%
2002 Q3	368.43 Thousand USD	555.04%
2002 Q2	56.24 Thousand USD	106.39%
2002 FY	747.94 Thousand USD	128.34%
2001 Q2	-248.21 Thousand USD	74.17%
2001 FY	-2.63 Million USD	-66.45%
2001 Q1	-960.83 Thousand USD	29.35%
2001 Q3	-326.56 Thousand USD	-31.57%
2001 Q4	-1.1 Million USD	-237.91%
2000 FY	-1.58 Million USD	0.0%
2000 Q4	-1.36 Million USD	0.0%

Peer Operating Income Comparison of PetMed Express, Inc.

Name	Operating Income	Operating Income Difference
CannBioRx Life Sciences Corp.	-13.47 Million USD	39.44%
BIMI International Medical Inc.	-15.33 Million USD	46.787%
China Jo-Jo Drugstores, Inc.	-3.53 Million USD	-130.92%
Harrow Health, Inc. 8.625% Senior Notes due 2026	580 Thousand USD	1507.241%
Harrow Health, Inc. 11.875% Senior Notes due 2027	431 Thousand USD	1993.735%
Leafly Holdings, Inc.	-7.05 Million USD	-15.757%
Leafly Holdings, Inc.	-7.05 Million USD	-15.757%
LifeMD, Inc.	-14.48 Million USD	43.669%
LifeMD, Inc.	-14.48 Million USD	43.669%
TRxADE HEALTH, Inc.	-7.26 Million USD	-12.372%
Walgreens Boots Alliance, Inc.	-14.07 Billion USD	99.942%

Global Stocks Search

PetMed Express, Inc. (PETS)

Operating Income Summary of PetMed Express, Inc.

Annual Operating Income Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Operating Income of PetMed Express, Inc. (2024 - 2000)

Peer Operating Income Comparison of PetMed Express, Inc.